What are Antibiotics?
Medication are medicines that are used to prevent and treat bacterial infections. They do not work against viruses like the common cold or flu, which are caused by viruses. Medication work by either killing or stopping the growth of bacteria. There are many different types of medication which work in different ways to treat different bacterial infections. Common medication include penicillins, cephalosporins, macrolides, quinolones and sulfonamides.
How Do Antibiotics Work?
Medication work by interfering with bacterial cell walls, protein production or nucleic acid synthesis which are essential for bacteria to multiply and spread. Some medication target the bacterial cell wall and prevent pathogens from forming a strong cell wall, causing the cell to burst. Others inhibit bacterial protein production by blocking aminoacyl-tRNA which prevents bacteria from synthesizing new essential proteins. Certain medication interfere with bacterial DNA replication by inhibiting DNA gyrase or other enzymes required for DNA transcription and repair. This prevents bacteria from multiplying and allows the host’s immune system to destroy the pathogen.
Types of Medication
Penicillins: These are among the oldest and most commonly used medication. Penicillin targets the bacterial cell wall and prevents crosslinking of peptidoglycan molecules, weakening the cell wall. It is effective against Gram-positive bacteria like streptococci and staphylococci. Examples include penicillin V, ampicillin and amoxicillin.
Cephalosporins: These are structurally similar to penicillins but have an additional functional group that makes them effective against a broader range of bacteria, including some Gram-negatives. First-generation cephalosporins include cephalexin and cefadroxil. Newer generations have an even broader spectrum of activity.
Macrolides: Macrolide medication like erythromycin, azithromycin and clarithromycin inhibit protein synthesis inside bacteria and are commonly used to treat respiratory tract infections. They work against cocci like streptococci, some staphylococci and atypical organisms.
Sulfonamides: These competitive inhibitors of para-aminobenzoic acid (PABA) disrupt folic acid synthesis in bacteria. Examples are sulfamethoxazole used together with trimethoprim to treat urinary tract infections and other infections.
Quinolones: Fluoroquinolones like ciprofloxacin, levofloxacin and ofloxacin target bacterial DNA gyrase, blocking DNA replication. They have a broad spectrum of activity against both Gram-negative and some Gram-positive bacteria. Quinolones are primarily used for urinary tract, respiratory and gastrointestinal infections.
Combination Medication
In some cases, two or more medication are used together, either to broaden the scope of bacteria killed or prevent resistance. For example, trimethoprim-sulfamethoxazole duo treats urinary tract infections. Combination pills of amoxicillin and clavulanic acid provide expanded Gram-negative coverage. Combination therapy is often needed for serious multidrug-resistant bacterial infections.
The Risk of Antibiotic Resistance
While medication have saved millions of lives since the 1940s, overprescribing and misuse have led to rising Antibiotic resistance worldwide. Bacteria can mutate or acquire resistance genes from neighboring bacteria through plasmids or transposons that allow them to survive even when exposed to medication. The more we use medication, the more bacteria develop new ways to evade them through these mutations or horizontal gene transfers. This poses serious risks as it will render existing medication ineffective against common infections. It is therefore important to only use medication judiciously and as prescribed by a doctor.
The Impact of Antibiotic Resistance
The rise of antibiotic resistance has significant health and economic implications as it leaves fewer treatment options for common and once easily treatable infections. Drug-resistant infections already cause tens of thousands of deaths annually in developed countries and are estimated to cause 10 million deaths each year worldwide by 2050 if no action is taken. Resistant infections also impose greater health and economic burden as alternative treatment options require hospitalization, longer illnesses, additional tests and greater costs. Some resistant bacteria like malaria and TB are becoming nearly untreatable without new antimicrobial development – but the pipeline for new antibiotic discovery and approval is slowing down compared to rising resistance globally.
In summary, medication have revolutionized medicine since the 20th century and saved countless lives by effectively treating bacterial infections. However, overuse and misuse have enabled bacteria to evolve defense mechanisms against several generations of medication through natural selection. This post-antibiotic era of multidrug-resistant pathogens now poses one of the gravest public health threats. It is critical that both appropriate antibiotic stewardship and new drug development efforts are accelerated to preserve the miracle discoveries of these lifesaving drugs. While no recommendations can be made directly here due to space constraints, judicious use of medication according to medical advice remains key at an individual level to tackle this growing epidemic of antibiotic resistance.
Get more insights on Antibiotics
 About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.